The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases

Pathology International

Volumn 61, Issue 3, 2011, Pages 116-121

  Nishikimi, Toshinori ^a,f   Tsuzuki, Toyonori ^a,f   Fujita, Takashi ^b,f   Sassa, Naoto ^e,f   Fukatsu, Akitoshi ^c,f   Katsuno, Satoru ^d,f   Yoshino, Yasushi ^e,f   Hattori, Ryohei ^e,f   Gotoh, Momokazu ^e,f  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b CHUKYO HOSPITAL   (Japan)

^c KOMAKI CITY HOSPITAL   (Japan)

^d Okazaki City Hospital   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

^f Tokai Urological Clinical Trial Group   (Japan)

Author keywords

Clear cell renal cell carcinoma; Growth pattern; Pathological prognostic parameter; Post operative; PT1a

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FUHRMAN GRADE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 79952082087     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02633.x     Document Type: Article

References (22)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628-31.
2. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: A need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-34.
3. Russo P, Jang TL, Pettus JA etal. Survival rates after resection for localized kidney cancer: 1989 to 2004. Cancer 2008; 113: 84-96.
4. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005; 173: 1889-92.
5. Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, tumor size and relative survival of patients with localized renal cell carcinoma: A surveillance, epidemiology and end results analysis. J Urol 2009; 181: 506-11.
6. Sorbellini M, Kattan MW, Snyder ME etal. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48-51.
7. Yaycioglu O, Roberts WW, Chan T, Epstein JI, Marshall FF, Kavoussi LR. Prognostic assessment of nonmetastatic renal cell carcinoma: A clinically based model. Urology 2001; 58: 141-5.
8. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009; 115: 2844-52.
9. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature. J Urol 2006; 175: 425-31.
10. Klatte T, Patard JJ, de Martino M etal. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008; 179: 1719-26.
11. Cheville JC, Blute ML, Zincke H, Lohse CM, Weaver AL. Stage pT1 conventional (clear cell) renal cell carcinmoa: Pathological features associated with cancer specific survival. J Urol 2001; 166: 453-6.
12. Argani P, Antonescu CR, Couturier J etal. PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002; 26: 1553-66.
13. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010; 479-89.
14. Remzi M, Ozsoy M, Klingler HC etal. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006; 176: 896-9.
15. Kutikov A, Fossett LK, Ramchandani P etal. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 2006; 68: 737-40.
16. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: The small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179: 1227-33.
17. Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA etal. Microvascular tumor invasion, tumor size and Fuhrman grade: A pathological triad for prognostic evaluation of renal cell carcinoma. J Urol 2007; 178: 425-8.
18. Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005; 174: 466-72.
19. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-24.
20. Japanese Urological Association and The Japanese Society of Pathology, Pathology. General Rule for Clinical and Pathological Studies on Bladder Cancer, 3rd edn. Tokyo: Kanehara & Co., Ltd., 2001.
21. Mikami Y, Manabe T, Epstein JI etal. Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement. Hum Pathol 2003; 34: 658-65.
22. Nakanuma Y, Zen Y, Harada K etal. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int 2010; 60: 167-74.